Cargando…
A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients
This retrospective cohort study investigated the progression risk of sequential complication in Asian type 2 diabetes (T2D) patients using the Taiwan Pay-for-Performance Diabetes Registry and claim data from November 2003 to February 2009. 226,310 adult T2D patients without complication were followe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623532/ https://www.ncbi.nlm.nih.gov/pubmed/26507664 http://dx.doi.org/10.1038/srep15687 |
_version_ | 1782397697183973376 |
---|---|
author | Cheng, Li-Jen Chen, Jeng-Huei Lin, Ming-Yen Chen, Li-Chia Lao, Chun-Huan Luh, Hsing Hwang, Shang-Jyh |
author_facet | Cheng, Li-Jen Chen, Jeng-Huei Lin, Ming-Yen Chen, Li-Chia Lao, Chun-Huan Luh, Hsing Hwang, Shang-Jyh |
author_sort | Cheng, Li-Jen |
collection | PubMed |
description | This retrospective cohort study investigated the progression risk of sequential complication in Asian type 2 diabetes (T2D) patients using the Taiwan Pay-for-Performance Diabetes Registry and claim data from November 2003 to February 2009. 226,310 adult T2D patients without complication were followed from diagnosis to complications, including myocardial infarction (MI), other ischemic heart disease (IHD), congestive heart failure (CHF), stroke, chronic kidney disease (CKD), retinopathy, amputation, death or to the end of study. Cumulative incidences (CIs) of first and second complications were analyzed in 30 and 4 years using the cumulative incidence competing risk method. IHD (29.8%), CKD (24.5%) and stroke (16.0%) are the most common first complications. The further development of T2D complications depends on a patient’s existing complication profiles. Patients who initially developed cardiovascular complications had a higher risk (9.2% to 24.4%) of developing IHD or CKD, respectively. All-cause mortality was the most likely consequence for patients with a prior MI (12.0%), so as stroke in patients with a prior MI (10.8%) or IHD (8.9%). Patients with CKD had higher risk of developing IHD (16.3%), stroke (8.9%) and all-cause mortality (8.7%) than end-stage renal disease (4.0%). Following an amputation, patients had a considerable risk of all-cause mortality (42.1%). |
format | Online Article Text |
id | pubmed-4623532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-46235322015-11-03 A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients Cheng, Li-Jen Chen, Jeng-Huei Lin, Ming-Yen Chen, Li-Chia Lao, Chun-Huan Luh, Hsing Hwang, Shang-Jyh Sci Rep Article This retrospective cohort study investigated the progression risk of sequential complication in Asian type 2 diabetes (T2D) patients using the Taiwan Pay-for-Performance Diabetes Registry and claim data from November 2003 to February 2009. 226,310 adult T2D patients without complication were followed from diagnosis to complications, including myocardial infarction (MI), other ischemic heart disease (IHD), congestive heart failure (CHF), stroke, chronic kidney disease (CKD), retinopathy, amputation, death or to the end of study. Cumulative incidences (CIs) of first and second complications were analyzed in 30 and 4 years using the cumulative incidence competing risk method. IHD (29.8%), CKD (24.5%) and stroke (16.0%) are the most common first complications. The further development of T2D complications depends on a patient’s existing complication profiles. Patients who initially developed cardiovascular complications had a higher risk (9.2% to 24.4%) of developing IHD or CKD, respectively. All-cause mortality was the most likely consequence for patients with a prior MI (12.0%), so as stroke in patients with a prior MI (10.8%) or IHD (8.9%). Patients with CKD had higher risk of developing IHD (16.3%), stroke (8.9%) and all-cause mortality (8.7%) than end-stage renal disease (4.0%). Following an amputation, patients had a considerable risk of all-cause mortality (42.1%). Nature Publishing Group 2015-10-28 /pmc/articles/PMC4623532/ /pubmed/26507664 http://dx.doi.org/10.1038/srep15687 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Cheng, Li-Jen Chen, Jeng-Huei Lin, Ming-Yen Chen, Li-Chia Lao, Chun-Huan Luh, Hsing Hwang, Shang-Jyh A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients |
title | A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients |
title_full | A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients |
title_fullStr | A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients |
title_full_unstemmed | A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients |
title_short | A competing risk analysis of sequential complication development in Asian type 2 diabetes mellitus patients |
title_sort | competing risk analysis of sequential complication development in asian type 2 diabetes mellitus patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623532/ https://www.ncbi.nlm.nih.gov/pubmed/26507664 http://dx.doi.org/10.1038/srep15687 |
work_keys_str_mv | AT chenglijen acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT chenjenghuei acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT linmingyen acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT chenlichia acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT laochunhuan acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT luhhsing acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT hwangshangjyh acompetingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT chenglijen competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT chenjenghuei competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT linmingyen competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT chenlichia competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT laochunhuan competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT luhhsing competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients AT hwangshangjyh competingriskanalysisofsequentialcomplicationdevelopmentinasiantype2diabetesmellituspatients |